Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Probing the diabetes and colorectal cancer relationship using gene - environment interaction analyses.
Dimou N; Kim AE; Flanagan O; Murphy N; Diez-Obrero V; Shcherbina A; Aglago EK; Bouras E; Campbell PT; Casey G; Gallinger S; Gruber SB; Jenkins MA; Lin Y; Moreno V; Ruiz-Narvaez E; Stern MC; Tian Y; Tsilidis KK; Arndt V; Barry EL; Baurley JW; Berndt SI; Bézieau S; Bien SA; Bishop DT; Brenner H; Budiarto A; Carreras-Torres R; Cenggoro TW; Chan AT; Chang-Claude J; Chanock SJ; Chen X; Conti DV; Dampier CH; Devall M; Drew DA; Figueiredo JC; Giles GG; Gsur A; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jordahl K; Kawaguchi E; Keku TO; Larsson SC; Le Marchand L; Lewinger JP; Li L; Mahesworo B; Morrison J; Newcomb PA; Newton CC; Obon-Santacana M; Ose J; Pai RK; Palmer JR; Papadimitriou N; Pardamean B; Peoples AR; Pharoah PDP; Platz EA; Potter JD; Rennert G; Scacheri PC; Schoen RE; Su YR; Tangen CM; Thibodeau SN; Thomas DC; Ulrich CM; Um CY; van Duijnhoven FJB; Visvanathan K; Vodicka P; Vodickova L; White E; Wolk A; Woods MO; Qu C; Kundaje A; Hsu L; Gauderman WJ; Gunter MJ; Peters U.
Br J Cancer
(Unknown)
Published: 2023
Local γδ T cells: translating promise to practice in cancer immunotherapy.
Br J Cancer
(Unknown)
Published: 2023
Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women wi…
Peremiquel-Trillas P; Gómez D; Martínez JM; Fernández-González S; Frias-Gomez J; Paytubi S; Pelegrina B; Pineda M; Brunet J; Ponce J; Matias-Guiu X; Bosch X; de Sanjosé S; Bruni L; Alemany L; Costas L; Díaz M.
Br J Cancer
(Unknown)
Published: 2023
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.
Hammarström M; Gabrielson M; Crippa A; Discacciati A; Eklund M; Lundholm C; Bäcklund M; Wengström Y; Borgquist S; Bergqvist J; Eriksson M; Tapia J; Czene K; Hall P.
Br J Cancer
(Unknown)
Published: 2023
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based s…
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Ebisch RMF; Melchers WJG; Bekkers RLM; Molijn AC; Quint WG; van Kemenade F; Meijer CJLM; Berkhof J; Heideman DAM.
Br J Cancer
(Unknown)
Published: 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Luke JJ; Fakih M; Schneider C; Chiorean EG; Bendell J; Kristeleit R; Kurzrock R; Blagden SP; Brana I; Goff LW; O'Hayer K; Geschwindt R; Smith M; Zhou F; Naing A.
Br J Cancer
(Unknown)
Published: 2023
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.
Fittall M; Liu J; Platt J; Ionescu M; Sheehan R; Johal S; Mew R; Clark J; Watts I; Tripathy A; Little M; Patel G; Panneerselvam H; Appanna N; Burke E; McKenzie H; Tilby M; Khan S; Lee LYW.
Br J Cancer
(Unknown)
Published: 2023
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
O'Mahony DG; Ramus SJ; Southey MC; Meagher NS; Hadjisavvas A; John EM; Hamann U; Imyanitov EN; Andrulis IL; Sharma P; Daly MB; Hake CR; Weitzel JN; Jakubowska A; Godwin AK; Arason A; Bane A; Simard J; Soucy P; Caligo MA; Mai PL; Claes KBM; Teixeira MR; Chung WK; Lazaro C; Hulick PJ; Toland AE; Pedersen IS; HEBON Investigators; Neuhausen SL; Vega A; de la Hoya M; Nevanlinna H; Dhawan M; Zampiga V; Danesi R; Varesco L; Gismondi V; Vellone VG; James PA; Janavicius R; Nikitina-Zake L; Nielsen FC; van Overeem Hansen T; Pejovic T; Borg A; Rantala J; Offit K; Montagna M; Nathanson KL; Domchek SM; Osorio A; García MJ; Karlan BY; GEMO Study Collaborators; De Fazio A; Bowtell D; AOCS Group; McGuffog L; Leslie G; Parsons MT; Dörk T; Speith LM; Dos Santos ES; da Costa AABA; Radice P; Peterlongo P; Papi L; Engel C; Hahnen E; Schmutzler RK; Wappenschmidt B; Easton DF; Tischkowitz M; Singer CF; Tan YY; Whittemore AS; Sieh W; Brenton JD; Yannoukakos D; Fostira F; Konstantopoulou I; Soukupova J; Vocka M; CZECANCA Consortium; Chenevix-Trench G; Pharoah PDP; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K; Consortium of Investigators of Modifiers of BRCA1/2; Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium.
Br J Cancer
(Unknown)
Published: 2023
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Constantin TA; Varela-Carver A; Greenland KK; de Almeida GS; Olden E; Penfold L; Ang S; Ormrod A; Leach DA; Lai CF; Ainscow EK; Bahl AK; Carling D; Fuchter MJ; Ali S; Bevan CL.
Br J Cancer
(Unknown)
Published: 2023
Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Kastinen M; Sirniö P; Elomaa H; Ahtiainen M; Väyrynen SA; Herzig KH; Meriläinen S; Aro R; Häivälä R; Rautio T; Saarnio J; Wirta EV; Helminen O; Seppälä TT; Kuopio T; Böhm J; Tuomisto A; Mecklin JP; Mäkinen MJ; Väyrynen JP.
Br J Cancer
(Unknown)
Published: 2023
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patien…
Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y.
Br J Cancer
(Unknown)
Published: 2023
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.
Heylen E; Verstraete P; Van Aerschot L; Geeraerts SL; Venken T; Timcheva K; Nittner D; Verbeeck J; Royaert J; Gijbels M; Uyttebroeck A; Segers H; Lambrechts D; Cools J; De Keersmaecker K; Kampen KR.
Br J Cancer
(Unknown)
Published: 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colo…
Kuboki Y; Terazawa T; Masuishi T; Nakamura M; Watanabe J; Ojima H; Makiyama A; Kotaka M; Hara H; Kagawa Y; Sugimoto N; Kawakami H; Takashima A; Kajiwara T; Oki E; Sunakawa Y; Ishihara S; Taniguchi H; Nakajima TE; Morita S; Shirao K; Takenaka N; Ozawa D; Yoshino T.
Br J Cancer
(Unknown)
Published: 2023
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patien…
Johnson ML; Wang JS; Falchook G; Greenlees C; Jones S; Strickland D; Fabbri G; Kennedy C; Elizabeth Pease J; Sainsbury L; MacDonald A; Schalkwijk S; Szekeres P; Cosaert J; Burris H.
Br J Cancer
(Unknown)
Published: 2023